ClinConnect ClinConnect Logo
Search / Trial NCT03353623

Immersive Virtual Environments and Wearable Haptic Devices in Rehabilitation of Children With Neuromotor Impairments

Launched by SCUOLA SUPERIORE SANT'ANNA DI PISA · Nov 20, 2017

Trial Information

Current as of August 20, 2025

Completed

Keywords

Immersive Virtual Environments Wearable Haptic Devices Neuromotor Impairments Rehabilitation Serious Game Randomized Controlled Trial

ClinConnect Summary

A Randomized Controlled Crossover Trial was designed to examine the usability and effectiveness of serious games and wearable haptic interfaces in rehabilitation of children with neuromotor impairments. The ethics board of Tuscany Region and the Italian Ministry of Health approved this study. All parents freely accepted the participation of their children in the study and provided written informed consent.

The investigators recruited eight patients, both male and female, 3 children with Cerebral Palsy (CP) and 5 children with Developmental Dyspraxia (DD) (mean age = 10,30±2,88 years), who ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • a history of neuromotor disorders (CP or DD)
  • a maximum age of 18 years
  • a minimum ability to actively grasp an object
  • the ability to understand simple instructions
  • low to severe impairments of the upper limbs
  • Exclusion Criteria:
  • epileptic patients
  • severe deficit in sensory perception of upper limb
  • severe visual impairments
  • severe cognitive diseases

About Scuola Superiore Sant'anna Di Pisa

Scuola Superiore Sant'Anna di Pisa is a prestigious Italian research institution renowned for its commitment to excellence in education and innovation. With a strong emphasis on interdisciplinary collaboration, the school focuses on advanced studies in the fields of health sciences, engineering, and social sciences. As a clinical trial sponsor, Scuola Superiore Sant'Anna leverages its cutting-edge research facilities and expertise to drive forward-thinking clinical investigations, aimed at improving patient outcomes and advancing medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the integrity and relevance of its clinical research initiatives.

Locations

Pisa, Pi, Italy

Patients applied

0 patients applied

Trial Officials

Ilaria Bortone, PhD

Study Chair

PERCRO Laboratory, Scuola Superiore Sant'Anna, via L. Alamanno 13b, 56010 Ghezzano, Pisa, Italy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials